BioCrossroads Blog Posts

More patients help drug firms pass 'valley of death'

August 11, 2014
Comment(1)
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
More

Most drug money in Indiana funds research. Is that good?

July 28, 2014
Comment(1)
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That's not the same thing as paying to market drugs, but it's hardly without controversy.
More

Life sciences jobs pack 2-for-1 punch

February 24, 2014
Comments(2)
While life sciences companies don’t rack up huge jobs numbers, their relatively high pay means that every job they create is worth two in the rest of the private sector.
More

Economic value of hospitals is not in jobs and revenue

October 7, 2013
Comments(7)
The real value of health care, pure and simple, is that it extends our productive lives. And that has a huge economic impact. Too bad Indiana's hospitals keep talking about something else.
More

BioCrossroads drops dreams for hospital innovation

August 15, 2013
Comments(7)
In this age of austerity, there's almost no chance of Indianapolis hospitals creating a Cleveland Clinic-like hub of innovation.
More

IT revolution coming to local health care

June 19, 2013
Comments(7)
Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
More

ADVERTISEMENT
Sponsored by
ADVERTISEMENT
ADVERTISEMENT